Revenue
15 thousand USD
2016 Q3 · USD
Exact inputs and evidence
- Revenue: 14995 USD Source
12 filing records in this dataset, filed from 2015-05-11 to 2016-11-25. Reported financial figures are available; chart coverage varies by period.
15 thousand USD
2016 Q3 · USD
-310.14%
2016 Q3 · %
-55.9 thousand USD
2016 Q3 · USD
3938 USD
51680000 shares
900.00% · 46.5 million shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2016-11-25.
Financial data available through: 2015-12-31.
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Prior period
USD 141,226
–
Current period
USD 100,312
–
100312 − 141226 = -40914 USD
141226 USD · 2014-01-01 – 2014-12-31
Inspect prior input Prior source100312 USD · 2015-01-01 – 2015-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 86,374
–
Current period
−USD 95,436
–
-95436 − -86374 = -9062 USD
-86374 USD · 2014-01-01 – 2014-12-31
Inspect prior input Prior source-95436 USD · 2015-01-01 – 2015-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 81,224
–
Current period
−USD 110,733
–
-110733 − -81224 = -29509 USD
-81224 USD · 2014-01-01 – 2014-12-31
Inspect prior input Prior source-110733 USD · 2015-01-01 – 2015-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Capital expenditure.
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2014 2014-01-01 – 2014-12-31 | 141226 | Unavailable | Unavailable | Unavailable | -86374 | Unavailable | Source
|
| 2015 2015-01-01 – 2015-12-31 | 100312 | Unavailable | Unavailable | Unavailable | -95436 | Unavailable | Source
|
Amounts are exact, in USD.
Sales over time and how quickly they are changing.
Revenue reported for each complete financial period.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2014 | Revenue | 141226 |
|
| 2015 | Revenue | 100312 |
|
Change in revenue from the same financial period one year earlier.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2014 | Year over year | No prior comparable period |
|
| 2015 | Year over year | -29% |
|
How much revenue becomes profit, and how much cash operations generate.
Operating income, net income and free cash flow as a share of revenue.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2014-12-31 | Operating margin | Not reported |
|
| 2015-12-31 | Operating margin | Not reported |
|
| 2014 | Net margin | -61.2% |
|
| 2015 | Net margin | -95.1% |
|
| 2014 | Free cash flow margin | Not reported |
|
| 2015 | Free cash flow margin | Not reported |
|
Cash generated by the company’s normal business operations.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2014 | Operating cash flow | -81224 |
|
| 2015 | Operating cash flow | -110733 |
|
Operating cash flow minus capital expenditure for the same period and unit.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2014 | Free cash flow | Unavailable |
|
| 2015 | Free cash flow | Unavailable |
|
Liabilities and short-term ability to meet obligations at each period end.
Total liabilities as a share of total assets.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2014-12-31 | Liabilities / assets | Not reported |
|
| 2015-12-31 | Liabilities / assets | Not reported |
|
Current assets divided by current liabilities.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2014 | Current assets / current liabilities | 0.2× |
|
| 2015 | Current assets / current liabilities | 0.05× |
|
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2014 2014-01-01 – 2014-12-31 | −USD 86,374 Exact valueExact value: -86374 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 81,224 Exact valueExact value: -81224 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2015 2015-01-01 – 2015-12-31 | −USD 95,436 Exact valueExact value: -95436 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 110,733 Exact valueExact value: -110733 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
12 filings · 364 latest values · 364 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001623077, 1623077, BMPP, bmpp, edgar:1623077, pxrb
Also known as BMP Holdings Inc., PixarBio Corp